Roche India's Efforts To Curb Fake Drugs Gain Popularity
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - While the global pharmaceutical industry struggles to arrive at a consensus on a new definition of counterfeit drugs, pharmaceutical company Roche India has introduced a cost-effective technology to tackle the problem called 'mass serialisation' that is fast gaining popularity among customers, say company officials